Pandemics

Health Systems Trust is a dynamic, not-for-profit organisation that supports the development of an equitable and comprehensive health system for the provision of quality health care in South and Southern Africa.

Health Systems Trust wishes to appoint a Clinical Mentor to support the clinical services in the Frances Baard District in the Northern Cape supported by the South Africa Sustainable Response to HIV and AIDS (SA SURE) project. SA SURE aims to strengthen local capacity to provide sustainable HIV and TB-related care and treatment services. This is a contract position linked to the duration of the project.

KEY RESPONSIBILITIES:
 

The purpose of this document is to provide guidance to national AIDS programmes and partners actively involved in the country response to AIDS on use of core indicators to measure and report on the national response.

Health Systems Trust is a dynamic, not-for-profit organisation that supports the development of an equitable and comprehensive health system for the provision of quality health care in South and southern Africa.

Health Systems Trust wishes to appoint a Leadership Mentor to provide technical assistance to maximise district and sub-district leadership by building local capacity in OR Tambo District that is supported by the Sustainable Response to HIV and AIDS (SA SURE) project. SA SURE aims to strengthen local capacity to provide sustainable HIV and TB-related care and treatment services. This is a one year, fixed-term contract positions, renewable based on funding availability and performance.

Health Systems Trust is a dynamic, not-for-profit organisation that supports the development of an equitable and comprehensive health system for the provision of quality health care in South and southern Africa.

Health Systems Trust wishes to appoint two Clinical Mentors to support clinical services in two of the districts supported by the South Africa Sustainable Response to HIV and AIDS (SA SURE) project. SA SURE aims to strengthen local capacity to provide sustainable HIV and TB-related care and treatment services. These are one year, fixed-term contract positions, renewable based on funding availability and performance.

This new UNAIDS report contains the latest data on numbers of new HIV infections, numbers of people receiving antiretroviral treatment, AIDS-related deaths and HIV among children. It highlights new scientific opportunities and social progress which are bringing the world closer to UNAIDS vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths.

The report also gives an overview of international and domestic HIV investments and the need for greater value for money and sustainability.

Calling for global solidarity and shared responsibility, the UNAIDS report contains commentaries from global and community leaders as well as people living with and affected by HIV.

The global war on drugs is driving the HIV/AIDS pandemic among people who use drugs and their sexual partners. Throughout the world, research has consistently shown that repressive drug law enforcement practices force drug users away from public health services and into hidden environments where HIV risk becomes markedly elevated. Mass incarceration of non-violent drug offenders also plays a major role in increasing HIV risk. This is a critical public health issue in many countries, including the United States, where as many as 25 percent of Americans infected with HIV may pass through correctional facilities annually, and where disproportionate incarceration rates are among the key reasons for markedly higher HIV rates among African Americans.

This report draws on recently collected field data from numerous countries where the International HIV/AIDS Alliance operates to explain why the funding crisis requires urgent action on the part of Global Fund donors and all other stakeholders. The Alliance’s recommendations for responding to the crisis are based on our analysis of the implications of funding shortfalls in the following specific areas: HIV treatment; HIV prevention; care and support; services for key populations at higher risk of HIV infection; and efforts to create an enabling environment.

HIV/AIDS imposes enormous economic, social, health, and human costs and will continue to do so for the foreseeable future. The challenge is particularly acute in Sub-Saharan Africa, home to two-thirds (22.5 million) of the people living with HIV/AIDS globally, and where HIV/AIDS has become the leading cause of premature death. But now, after decades of misery and frustration with the disease, there are signs of hope. HIV prevalence rates in Africa are stabilizing. This book sheds light on these concerns by analyzing the fiscal implications of HIV/AIDS in Southern Africa, the epicenter of the epidemic. It uses the toolbox of public finance to assess the sustainability of HIV/AIDS programs.

This year's report lays out a three-part, science-based agenda for ending the AIDS epidemic in our lifetimes and synthesizes the actions needed across the spectrum of existing, emerging and long-term biomedical HIV prevention tools that could change the AIDS response forever. As you will see, we have tried to capture the need to deliver, demonstrate and develop (and combine) across a range of prevention options.